Gene Therapy for Neurological Disorders Europe is dedicated to solving the translational drug development challenges encountered in the development of gene therapies for neurological disorders.

Industry pioneers from the leading pharma and biotech companies including Avexis, uniQure, and Biogen will share how to improve the translatability of small and large animal models, develop innovative delivery approaches to guarantee delivery of vector and understand the realities of immunogenicity challenges in the CNS.

Join this definitive, niche digital conference to accelerate the development of your gene therapy pipeline and address the significant unmet need in neurological indications.